Skip to main content
. 2019 Feb 27;10:154. doi: 10.3389/fphar.2019.00154

FIGURE 7.

FIGURE 7

Metformin treatment reduces cardiac hypertrophy in I/R-challenged hearts. (A) Representative images of wheat germ agglutinin (WGA) staining of heart frozen tissue sections. Mice were subjected to 30 min of cardiac ischemia and 14 days of reperfusion. Metformin treatment (5 mg/kg/day, i.p.) started at 15 min of post-reperfusion and continued for 14 days. Scale bar is 25 μM. (B). Quantification of cell size from (A). (C). qRT-PCR analysis of the expression level of the hypertrophic marker BNP. Data are presented as mean ± SEM. Statistical analysis was carried out by one-way ANOVA: P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 between indicated conditions.